|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||10.86 - 11.43|
|52 Week Range||3.40 - 19.87|
|PE Ratio (TTM)||81.84|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Aphria receives third-party independent GMP certification of Leamington growing and processing facilities
LEAMINGTON, ON, March 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced it has received third-party independent GMP certification of its Leamington, Ontario growing and processing facilities. Granted by internationally-renowned firm SGS, the certification is for the current Good Manufacturing Practice ("cGMP") standards of CFR 21 parts 210/211 established by the United States Food and Drug Administration ("USFDA") for Active Pharmaceutical Ingredients and Finished Pharmaceuticals.
Aphria's Australian-based partner Althea receives Medical Cannabis License for cultivation
LEAMINGTON, ON, March 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") was granted a Medical Cannabis License (the "License") by the Australian Government's Office of Drug Control ("Office of Drug Control"). The License provides Althea with authorization to cultivate medical cannabis, enabling the Australian Company to begin immediate construction on a state-of-the art greenhouse facility in Victoria.
Aphria More Than Triples Production Capacity with Health Canada Approval for Part III Expansion
LEAMINGTON, ON, March 13, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that the Company received a license amendment from Health Canada that provides Aphria with additional production space of 200,000 square feet, as part of its Part III expansion at its facility in Leamington, Ontario. This will more than triple the Company's production capacity of medical cannabis from 9,000 kg annually to 30,000 kg annually.
MedReleaf currently has a completed facility of 55,000 square feet in Markham, Ontario. As of the date of this writing, Phase 1 of the Bradford facility is complete, and together with the Markham facility, it has a cultivation capacity of 17,000 kilograms per year.
Currently, the company has 101,000 square feet of licensed capacity, which includes the recently added space of 57,000 square feet. The company also has two more expansion projects underway, which will build on to its current Part II facility.
In the earlier part of the series, we discussed how Aurora Cannabis (ACB) (ACBFF) plans to fund its production facility in Denmark. Aurora Cannabis is not the only Canadian cannabis-licensed producer to eye international markets. On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.
Aurora Cannabis (ACB) (ACBFF), another licensed cannabis producer, is also doing its part to expand its capacity. Aurora Cannabis currently has a total licensed capacity of 95,000 square feet, which makes up ~5% of the company’s total capacity, including that which is under construction and in design. Aurora Cannabis has ~848,000 square feet of capacity under construction, primarily in the provinces of Alberta and Quebec.
It’s natural that companies are anticipating high provincial demand for recreational cannabis (HMLSF) and ramping up their production capacities. Canopy Growth (WEED) recently said, “It will take two years and possibly longer to rollout the full network of regulated cannabis retail stores that is required to satisfy consumer demand.” This also gives producers time to gradually build their capacities. Let’s look at what Canopy Growth is up to on that front.
Ahead of the legalization of recreational cannabis, companies are ramping up their production capacities. Currently, Canada has a total of 91 licensed producers, of which 48 are in the province of Ontario. How a province goes about selecting its supplier will be critical for big and small players alike.
In anticipation of recreational cannabis’s legalization at the federal level in Canada (HMMJ), provinces have been doing their best to prepare. In most provinces, government agencies will oversee the procurement, distribution, and retail of recreational cannabis. On the other hand, government agencies in some provinces will oversee the procurement and distribution but will also allow private retailers to sell recreational cannabis to customers. These provinces include British Columbia, Alberta, Saskatchewan, and Manitoba.
In addition, by tracking analysts’ revisions, we can determine the direction of changes in estimates. In this article, we’ll discuss analysts’ estimate revisions for 2018 and 2019. In the chart above, we can see analysts’ estimate revisions for six companies for 2018 since the beginning of the year.
Hiku Brands Applies for Cannabis Oil License, Launches Innovative Extraction Program in Partnership With Vitalis and Secures Prairies Expansion Rights for Tokyo Smoke Brand